Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexington Biosciences Inc LXGTF

Registered Plan Private Investments Inc is a private investment platform company that allows investors to use their Registered Plans (including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans) at their direction to invest in private companies by purchasing tracking shares in RPPI, which in turn uses these proceeds to invest in the specific private company chosen by the investor.


Recent & Breaking News (EXPM:LXGTF)

CSE Bulletin: Delist - Lexington Biosciences Inc. (LNB)

Newsfile May 1, 2020

Lexington Biosciences Announces Appointment of CEO

GlobeNewswire April 16, 2020

Lexington Biosciences Provides Corporate Update

GlobeNewswire February 20, 2020

Lexington Biosciences License Terminated

GlobeNewswire February 12, 2020

Lexington Biosciences Converts Amounts Owed to Unsecured Demand Loans

GlobeNewswire October 4, 2019

IIROC Trade Resumption - LNB

Canada NewsWire April 26, 2019

Lexington Biosciences to Consolidate its Common Shares

GlobeNewswire April 25, 2019

IIROC Trading Halt - LNB

Canada NewsWire April 24, 2019

Lexington Biosciences Provides Update on Financial Situation

GlobeNewswire April 2, 2019

Lexington Biosciences Announces Termination of Private Placement

GlobeNewswire February 14, 2019

Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement

GlobeNewswire November 29, 2018

Lexington Provides Q3 Corporate Review

GlobeNewswire October 23, 2018

Lexington Announces Non-Brokered Private Placement

GlobeNewswire August 27, 2018

Lexington Announces First Multicenter Clinical Study Site

GlobeNewswire August 21, 2018

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

GlobeNewswire July 25, 2018

Lexington Biosciences Announces Results of Annual General Meeting

GlobeNewswire July 2, 2018

Lexington Biosciences Concludes Initial HeartSentry Clinical Study

GlobeNewswire June 27, 2018

Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing

GlobeNewswire June 11, 2018

Lexington Engages with Major Canadian University and Provides Clinical Trial Update

GlobeNewswire May 8, 2018

Lexington Announces Brokered Private Placement

GlobeNewswire May 4, 2018